Comparison of Nodal Risk Formula and MR Lymphography for Predicting Lymph Node Involvement in Prostate Cancer-Reference-Cited by-同舟云学术

Comparison of Nodal Risk Formula and MR Lymphography for Predicting Lymph Node Involvement in Prostate Cancer

Published:2011-09 Issue:1 Volume:81 Page:8-15
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Deserno Willem M.L.L.G.,Debats Oscar A.,Rozema Tom,Fortuin Ansje S.,Heesakkers Roel A.M.,Hoogeveen Yvonne,Peer Petronella G.M.,Barentsz Jelle O.,van Lin Emile N.J.T.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference29 articles.

1. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials;Nguyen;J Clin Oncol,2008

2. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer, and confusion about the results of the randomized trials;Roach;J Clin Oncol,2008

3. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01;Pommier;J Clin Oncol,2007

4. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413;Roach;J Clin Oncol,2003

5. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?;Bader;J Urol,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphotropic Nanoparticle-enhanced MRI in Prostate Cancer: Value and Therapeutic Potential;Current Urology Reports;2014-01-16

2. Individualized image-based lymph node irradiation for prostate cancer;Nature Reviews Urology;2013-05-28

3. Overview of Randomized Controlled Treatment Trials for Clinically Localized Prostate Cancer: Implications for Active Surveillance and the United States Preventative Task Force Report on Screening?;JNCI Monographs;2012-12-01

4. Value of PET/CT and MR Lymphography in Treatment of Prostate Cancer Patients With Lymph Node Metastases;International Journal of Radiation Oncology*Biology*Physics;2012-11